This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Will Expedia (EXPE) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Expedia (EXPE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Investors Need to Take Advantage of These 2 Retail and Wholesale Stocks Now
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
EXPE or MELI: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
EXPE vs. MELI: Which Stock Is the Better Value Option?
Airbnb Stock Trades Higher Than Industry at 6.54X P/S: Hold or Fold?
by Aniruddha Ganguly
ABNB is riding on strong Nights & Experiences Booked and growing usage of its app amid challenging macroeconomic conditions and stiff competition.
3 Key Reasons to Buy JD.com Stock Beyond the 52.8% Surge in a Year
by Vasundhara Sawalka
JD's 52% surge, 8.58X P/E and global expansion make it a must-buy. With AI innovation and UEFA partnership, this e-commerce leader is set for 2025 growth.
Expedia Falls 7% in a Month: Should You Buy, Sell or Hold the Stock?
by Zacks Equity Research
EXPE plans new initiatives for aiding growth in 2025, but with intense competition and weak guidance, investors can wait for better entry points.
Betting on Female CEOs: 5 Stocks to Buy This Women's Day
by Rimmi Singhi
This Women's Day, celebrate female leadership. Invest in GM, LUMN, PCG, EXPE and C, which are women-led companies driving growth, innovation and returns.
EXPE vs. CPNG: Which Stock Is the Better Value Option?
by Zacks Equity Research
EXPE vs. CPNG: Which Stock Is the Better Value Option?
Expedia (EXPE) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Expedia (EXPE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Travelzoo Set to Report Q4 Earnings: Buy, Sell or Hold the Stock?
by Vasundhara Sawalka
TZOO presents a mixed investment case ahead of fourth-quarter earnings, combining discounted valuation and slower expected growth in revenues.
Zacks Investment Ideas feature highlights: Palomar, Expedia Group and Gambling.com
by Zacks Equity Research
Palomar, Expedia Group and Gambling.com have been highlighted in this Investment Ideas article.
3 High-Growth Momentum Stocks to Buy for 2025
by Ethan Feller
Gambling.com, Expedia Group and Palomar Holdings stocks have it all - strong growth, fair valuations, top Zacks Ranks and strong price momentum
Airbnb Shares Jump 12% in a Week: Buy, Sell or Hold the Stock?
by Aniruddha Ganguly
ABNB is riding on strong Nights & Experiences Booked and growing usage of its app amid challenging macroeconomic conditions and stiff competition.
Zacks.com featured highlights include General Motors, Expedia Group, Phibro Animal Health and Pilgrim's Pride
by Zacks Equity Research
General Motors, Expedia Group, Phibro Animal Health and Pilgrim's Pride are part of the Zacks Screen of the Week article.
Should First Trust Growth Strength ETF (FTGS) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FTGS
4 PEG-Based Value Stocks to Shield Your Portfolio From Trade War
by Urmimala Biswas
Here are four PEG-driven GARP stocks, GM, EXPE, PAHC and PPC, which qualify our screening criteria.
How to Find Strong Retail and Wholesale Stocks Slated for Positive Earnings Surprises
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Are You Looking for a Top Momentum Pick? Why Expedia (EXPE) is a Great Choice
by Zacks Equity Research
Does Expedia (EXPE) have what it takes to be a top stock pick for momentum investors? Let's find out.
EXPE or GLBE: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
EXPE vs. GLBE: Which Stock Is the Better Value Option?
Top Research Reports for Procter & Gamble, Boston Scientific & ConocoPhillips
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including The Procter & Gamble Company (PG), Boston Scientific Corporation (BSX) and ConocoPhillips (COP), as well as a micro-cap stock Kewaunee Scientific Corporation (KEQU).
EXPE Q4 Earnings Beat Estimates, Stock Up on Solid Bookings Growth
by Zacks Equity Research
Expedia's fourth-quarter 2024 results benefit from an increase in B2B and advertising revenues.
Expedia (EXPE) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Expedia (EXPE) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Flat Day Ahead of Friday Jobs Report; Q4 Results for AMZN, SKX, EXPE
by Mark Vickery
+170K jobs are expected to have been filled last month, below the December tally of +256K.
Expedia (EXPE) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Expedia (EXPE) delivered earnings and revenue surprises of 15.46% and 3.52%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
PC Connection (CNXN) Q4 Earnings and Revenues Lag Estimates
by Zacks Equity Research
PC Connection (CNXN) delivered earnings and revenue surprises of -13.33% and 1.02%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?